Healthcare -
Biotechnology - NASDAQ - US
$ 0.5755
2.97 %
$ 168 M
Market Cap
-0.73
P/E
LYEL - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities LYEL - Lyell Immunopharma, Inc.
1.74 M
LAST VALUE
-93.41%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR